Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;42(6-7):1099-1109.
doi: 10.1016/j.radmeas.2007.05.042.

Implementing EPR Dosimetry for Life-Threatening Incidents: Factors Beyond Technical Performance

Affiliations

Implementing EPR Dosimetry for Life-Threatening Incidents: Factors Beyond Technical Performance

Ann Barry Flood et al. Radiat Meas. 2007 Jul.

Abstract

Starting with the assumption that a device to detect unplanned radiation exposures is technically superior to current technology, we examine the additional stakeholders and processes that must be considered to move the device from the lab into use. The use is to provide reliable information to triage people for early treatment of exposure to ionizing radiation that could lead to the Acute Radiation Syndrome. The scenario is a major accident or terrorist event that leaves a large number of people potentially exposed, with the resulting need to identify those to treat promptly or not. In vivo EPR dosimetry is the exemplar of such a technique.Three major areas are reviewed: policy considerations, regulatory clearance, and production of the device. Our analysis of policy-making indicates that the current system is very complex, with multiple significant decision-makers who may have conflicting agendas. Adoption of new technologies by policy-makers is further complicated because many sources of expert input already have made public stances or have reasons to prefer current solutions, e.g., some may have conflicts of interest in approving new devices because they are involved with the development or adoption of competing techniques. Regulatory clearance is complicated by not being able to collect evidence via clinical trials of its intended use, but pathways for approval for emergency use are under development by the FDA. The production of the new device could be problematical if the perceived market is too limited, particularly for private manufacturers; for in vivo EPR dosimetry the potential for other uses may be a mitigating factor.Overall we conclude that technical superiority of a technique does not in itself assure its rapid and effective adoption, even where the need is great and the alternatives are not satisfactory for large populations. Many important steps remain to achieve the goals of approval and adoption for use.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention (CDC) Acute radiation syndrome: A fact sheet for physicians. 2005. Retrieved December 25, 2006 from http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp.
    1. Department of Homeland Security (DHS) National Response Plan. Initial Draft. 2002. Retrieved December 28, 2006 from http://www.nemaweb.org/docs/national_response_plan.pdf.
    1. Department of Homeland Security (DHS) National Response Plan. 2004. Retrieved December 28, 2006 from http://www.dhs.gov/xprepresp/committees/editorial_0566.shtm.
    1. Department of Homeland Security (DHS) Remarks by Secretary of Homeland Security Michael Chertoff at the Brookings Institution; Washington DC: Jun 1, 2006a. 2006. . Retrieved January 27, 2007 from http://www.dhs.gov/xnews/speeches/speech_0283.shtm.
    1. Department of Homeland Security (DHS) Preparedness and Response. 2006b. Retrieved December 25, 2006 from http://www.dhs.gov/xprepresp/

LinkOut - more resources